Preprint · OA
via OpenAlex
Modelling frontotemporal dementia using patient-derived induced pluripotent stem cells
Georgie Lines, Jackie M. Casey, Elisavet Preza, Selina Wray
Molecular and Cellular Neuroscience · 2020 · ▲ 28 citations
Abstract
This 2020 study in Molecular and Cellular Neuroscience examines the use of patient-derived induced pluripotent stem cells for modelling frontotemporal dementia.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1016/j.mcn.2020.103553
- Canonical
- link ↗
- Fetched
- 2026-06-19 MST
Cite this
APA
Lines, G., Casey, J.M., Preza, E., & Wray, S. (2020). Modelling frontotemporal dementia using patient-derived induced pluripotent stem cells. <em>Molecular and Cellular Neuroscience</em>. https://doi.org/10.1016/j.mcn.2020.103553
Vancouver
Lines G, Casey JM, Preza E, Wray S. Modelling frontotemporal dementia using patient-derived induced pluripotent stem cells. Molecular and Cellular Neuroscience. 2020. doi:10.1016/j.mcn.2020.103553.
BibTeX
@unpublished{georgie2020Modell,
title = {Modelling frontotemporal dementia using patient-derived induced pluripotent stem cells},
author = {Georgie Lines and Jackie M. Casey and Elisavet Preza and Selina Wray},
journal = {Molecular and Cellular Neuroscience},
year = {2020},
doi = {10.1016/j.mcn.2020.103553},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Journal of materials research/Pratt's guide to venture capital sources 2018
Citation only
Regenerative medicine: Induced pluripotent stem cells and their benefits on accelerated bone tissue reconstruction using scaffolds
Nutrients 2026
Open access · OA
Riboflavin as a Regulator of Cellular Metabolism: From the Classic Vitamin B2 to a Key Redox Factor
Cell Research 2011
Open access · OA
Molecular insights into the heterogeneity of telomere reprogramming in induced pluripotent stem cells
Stem Cells 2011
Open access · OA
Concise Review: Induced Pluripotent Stem Cell‐Derived Mesenchymal Stem Cells: Progress Toward Safe Clinical Products
Cells 2022
Open access · CC-BY
The Induced Pluripotent Stem Cells in Articular Cartilage Regeneration and Disease Modelling: Are We Ready for Their Clinical Use?
2020
Citation only